Benkessou
Paris, 75016, France
NCT Number: NCT04300738
The aim of our study is to assess the Cardiovascular risk and the quality of the arteries by comparing the Coronary Calcium Score SCC measured with a CT scann and the Pulse Wave Velocity PWV measured with pOpmeter for the prognosis at 6 months of clinical events.
Is there a superiority of PWV compared to SCC:
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75016, France
Two method of cardiovascular risk screening are compared in patient going for Coronary Calcium Score measurement in a outpatient clinic. Ct Scann is expensive, learning time is for at least 2 years, and the reliability is operator dependent.
The Pulse Wave Velocity is measured using a new device with half an hour learning curve, and you get a result within 2 minutes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measurement with 2 devices
Other names: PWV measurement with pOpmètre
Time frame: 12 months
Coronary Calcium Score,
Time frame: 12 months
Clinique Bizet
Other
Acronym: VOP-SCC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03558893
Cardiovascular Diseases, Cardiovascular Risk Factor
Portland, Oregon, United States
View Trial DetailsNCT03039023
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT04731363
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT03336255
Cardiovascular Risk Factor
Chicago, Illinois, United States
View Trial Details